Capital Health Launches Antibody Testing Initiative for COVID-19

 Capital Health Launches Antibody Testing Initiative for COVID-19

Capital Health Launches Antibody Testing Initiative for COVID-19

Shots:

  • Capital Health has started an IgG Ab research initiative in mid-Apr with 1200+ employee volunteers contributing blood samples for the study and then collaborated with FlowMetric to create a screening program following the industry’s exacting protocols and high ethical standards
  • The collaboration has demonstrated how regional medical centers have important roles in the development of new diagnostics and treatments. The focus of the study is to inform the medical community about the existence of immunity to COVID-19 in health care settings and eventually at the large population
  • An infected person produces specific IgG Ab that can be detected in blood samples while the presence of specific Ab indicates that a person has produced an immune response to COVID-19

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Capital Health

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post